Skip to main navigation
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Contact
  • Programs
    • HBV
    • Pipeline
  • Patients
    • Commitment
    • Clinical Trials
    • Resources
  • Sustainability
    • Overview
    • Business Ethics
    • Access to Health Care
    • Human Capital
    • Environment, Health and Safety
  • Collaborations
  • Investors
    • News & Events
    • Corporate Governance
    • Financials & Filings
    • Stock Information
  • Careers
    • Culture
    • Benefits
    • Opportunities
On the
  • Press Releases
  • Events & Presentations

Event Details

EASL 2020 – Digital Annual Meeting

Aug 27 - Aug 29, 2020

Supporting Materials

Oral Presentation - Vebicorvir (ABI-H0731) Phase 2 Data (Study 211), HBeAg Negative Patients 825.6 KB
Late-Breaker Poster – Vebicorvir (ABI-H0731) Phase 2 Data (Study 211), HBeAg Positive Patients 514.4 KB
Late-Breaker Poster – ABI-H2158 Phase 1b Data 692 KB
Poster – Assembly’s Highly Sensitive Assay Data 779.6 KB
Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds
Search Investors

Contact Us

833.509.4583
info@assemblybio.com
About Programs Patients Collaborations Investors Careers

© 2021 Assembly Biosciences, Inc.